NTRR Targets New Partners in $1.7 Billion Medical Marijuana Industry

NTRR Targets New Partners in $1.7 Billion Medical Marijuana Industry

SARASOTA, Fla.--(BUSINESS WIRE)-- Neutra Corp. (OTCBB: NTRR) announced today that the company has narrowed its list of mergers and acquisitions targets down to two. The company plans to move forward with letters of intent to form new joint ventures or partnerships in the booming $1.7 billion U.S. medical marijuana (MMJ) industry.

Last month, NTRR's executive leadership visited with leading innovators in California's medical marijuana (MMJ) industry—the nation's largest, by far. The company has explored a number of entry points into the cannabis market, including the delivery of improved production support technologies, logistic services to emerging players in the MMJ space as well as the development of high-efficiency production systems.

"We've done our homework on this fast-growing field of natural wellness solutions, and now we're ready to move forward with negotiations with innovators on the industry's cutting edge," said NTRR CEO Sydney Jim. "We expect to announce signed letters of intent with exciting, emerging cannabis companies in the coming days and weeks."

These potentially lucrative opportunities will be pursued by Cannabis Technologies, Inc., the new Los Angeles-based subsidiary founded by NTRR to engineer its market strategy in the MMJ sector. The market potential for new innovations is high: Demand for high-quality medicinal buds could potentially spur retail medical marijuana sales to an estimated $6 billion by 2018.

Neutra Corp. is dedicated to commercializing innovative, all-natural products to compete in the fast-growing medical marijuana sector alongside Cannabis Science Inc. (PINK: CBIS), Medical Marijuana Inc. (PINK: MJNA), HEMP Inc. (PINK: HEMP) and Growlife Inc. (PINK: PHOT).

For more information on NTRR's MMJ initiative, please visit www.neutracorp.com/investors.html.

About Neutra Corp.

Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products and services as well as protective, anti-microbial coatings for indoor and outdoor surfaces. For investing information and performance data, please visit www.neutracorp.com/investors.html

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Neutra Corp.
Sydney Jim, 713-821-1486
President and CEO

KEYWORDS:   United States  North America  Florida


The article NTRR Targets New Partners in $1.7 Billion Medical Marijuana Industry originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.